SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

SunTrust Robinson Humphrey Maintains Buy on Alexion Pharmaceuticals, Lowers Price Target to $135

SunTrust Robinson Humphrey maintains Alexion Pharmaceuticals (NASDAQ:ALXN) with a Buy and lowers the price target from $141 to $135.

Benzinga · 05/08/2020 14:30

SunTrust Robinson Humphrey maintains Alexion Pharmaceuticals (NASDAQ:ALXN) with a Buy and lowers the price target from $141 to $135.